AbbVie Inc. buy exploration
Summary
This prediction ended on 18.09.17 with a price of €76.82. The prediction had a final performance of 16.51%. exploration has 50% into this predictionAbbVie (ABBV) is a multinational biopharmaceutical company based in North Chicago, Illinois. It was spun off as a separate entity from Abbott Laboratories in 2013 and is primarily focused on the development and commercialization of drugs for the treatment of conditions such as immunology, oncology, and neuroscience. Its key product is Humira, which is used to treat a range of autoimmune diseases, generating a significant portion of the company's revenue. The company also has a pipeline of promising products in various stages of development, making it a reputable player in the pharmaceutical industry.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
AbbVie Inc. | -5.422% | -5.422% | 10.267% | 51.809% |
iShares Core DAX® | -0.205% | 2.949% | 17.330% | 18.203% |
iShares Nasdaq 100 | 1.613% | 5.877% | 37.451% | 56.281% |
iShares Nikkei 225® | -0.740% | -1.256% | 11.847% | 5.531% |
iShares S&P 500 | 0.267% | 3.240% | 29.308% | 46.371% |
Comments by exploration for this prediction
In the thread AbbVie Inc. diskutieren
AbbVie: fallende Flagge deutet Trendfortsetzung an
- nach dreimonatigen Seitwärtsphase begann Anfang Juni der Trend aufwärts zu steigen.
- Ende Juni konsolidierten die Kurse in eine fallende Flagge, was in der Regel eine Trendfortsetzungsformation darstellt.
- mit Ausbruch aus diese Flagge sollten die Kurse nun weiter steigen.
- da die erste Trendphase ca. 4 Wochen dauerte, kann davon ausgegangen werden, dass die nun folgende Phase max. 4 dauern wird.